Cointime

Pharma Two B

company

About

Pharma Two B develops clinical products based on approved drugs, focusing on fixed-dose-combinations of two or more drugs for PD and cancer.

  • 1 - 10

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson's disease (PD) and Cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Pharma Two B has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Feb 27, 2017 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 27, 2017 Series C $30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Pharma Two B is funded by 1 investors. Generali Financial Holding are the most recent investors.
Investor Name Lead Investor Funding Round
Generali Financial Holding — Series C
Cointime
Содержание
компания